Clinical Trials Browser

Phase 2 × Lymphoma, Large-Cell, Anaplastic × Vinorelbine × Clear all

NCT03443128 2025-02-13

Vinorelbine for Recurrent ALCL-2017

Phase 2 Completed

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT03397953 2022-07-26

Vinorelbine for Recurrent ACLC

Phase 2 Completed

Recurrence, Lymphoma, Large-Cell, Anaplastic